{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T17:01:39Z","timestamp":1775149299267,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":2274,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Vascular Surgery"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.jvs.2007.02.031","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T13:07:09Z","timestamp":1180962429000},"page":"A74-A81","source":"Crossref","is-referenced-by-count":33,"special_numbering":"S","title":["Molecular engineering of vein bypass grafts"],"prefix":"10.1016","volume":"45","author":[{"given":"Michael S.","family":"Conte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvs.2007.02.031_bib1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00000658-200103000-00021","article-title":"Impact of increasing comorbidity on infrainguinal reconstruction: a 20-year perspective","volume":"233","author":"Conte","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1096\/fasebj.12.1.43","article-title":"The ideal small arterial substitute: a search for the Holy Grail?","author":"Conte","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.jvs.2007.02.031_bib3","series-title":"Vascular surgery","first-page":"98","article-title":"Infrainguinal bypass","author":"Belkin","year":"2000"},{"key":"10.1016\/j.jvs.2007.02.031_bib4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.ejcts.2006.06.015","article-title":"In vivo (animal) models of vein graft disease","volume":"30","author":"Schachner","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0033-0620(91)90019-I","article-title":"Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries","volume":"34","author":"Cox","year":"1991","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jvs.2007.02.031_bib6","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1078-5884(05)80218-7","article-title":"Pathophysiology of vein graft failure: a review","volume":"9","author":"Davies","year":"1995","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib7","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1067\/mva.2002.129112","article-title":"Genetic interventions for vein bypass graft disease: a review","volume":"36","author":"Conte","year":"2002","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm750","article-title":"Inhibitor of apoptosis protein survivin regulates vascular injury","volume":"8","author":"Blanc-Brude","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.jvs.2007.02.031_bib9","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jvs.2005.01.006","article-title":"Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype","volume":"41","author":"Simosa","year":"2005","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib10","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1161\/01.ATV.0000183885.66153.8a","article-title":"Regulation of vein graft hyperplasia by survivin, an inhibitor of apoptosis protein","volume":"25","author":"Wang","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2007.02.031_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.surg.2006.04.004","article-title":"Angiotensin II and tumor necrosis factor-alpha upregulate survivin and Kruppel-like factor 5 in smooth muscle cells: potential relevance to vein graft hyperplasia","volume":"140","author":"Bafford","year":"2006","journal-title":"Surgery"},{"key":"10.1016\/j.jvs.2007.02.031_bib12","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tcm.2006.02.002","article-title":"Survivin regulation of vascular injury","volume":"16","author":"Conte","year":"2006","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jvs.2007.02.031_bib13","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1126\/science.2660259","article-title":"Progress toward human gene therapy","volume":"244","author":"Friedmann","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.jvs.2007.02.031_bib14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1126\/science.8493530","article-title":"The basic science of gene therapy","volume":"260","author":"Mulligan","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.jvs.2007.02.031_bib15","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.270.5235.404","article-title":"Transfer of genes to humans: early lessons and obstacles to success","volume":"270","author":"Crystal","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jvs.2007.02.031_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/83324","article-title":"Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics","volume":"7","author":"Kay","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jvs.2007.02.031_bib17","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJM199605023341809","article-title":"Adenoviruses as gene delivery vehicles","volume":"334","author":"Wilson","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2007.02.031_bib18","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0008-6363(97)00098-9","article-title":"Efficient adenoviral gene transfer to early venous bypass grafts: comparison with native vessels","volume":"35","author":"Channon","year":"1997","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jvs.2007.02.031_bib19","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1172\/JCI118367","article-title":"Adenovirus-mediated gene transfer into normal rabbit arteries results in prolonged vascular cell activation, inflammation, and neointimal hyperplasia","volume":"96","author":"Newman","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jvs.2007.02.031_bib20","first-page":"497","article-title":"Adeno-associated virus vectors for vascular gene delivery","volume":"80","author":"Lynch","year":"1997","journal-title":"Circ Res"},{"key":"10.1016\/j.jvs.2007.02.031_bib21","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1067\/mva2000.106951","article-title":"Gene delivery to in situ veins: differential effects of adenovirus and adeno-associated viral vectors","volume":"31","author":"Eslami","year":"2000","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib22","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/hc3901.097505","article-title":"Magnetic resonance imaging permits in vivo monitoring of catheter-based vascular gene delivery","volume":"104","author":"Yang","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jvs.2007.02.031_bib23","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0022-2828(03)00136-6","article-title":"Third-generation lentivirus vectors efficiently transduce and phenotypically modify vascular cells: implications for gene therapy","volume":"35","author":"Dishart","year":"2003","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.jvs.2007.02.031_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1242\/jcs.97.3.399","article-title":"Antisense strategies in cell and developmental biology","volume":"97","author":"Colman","year":"1990","journal-title":"J Cell Sci"},{"key":"10.1016\/j.jvs.2007.02.031_bib25","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1056\/NEJM199602013340508","article-title":"Molecular medicine: antisense oligonucleotide therapy","volume":"334","author":"Askari","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jvs.2007.02.031_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/324429a0","article-title":"The Tetrahymena ribozyme acts like an RNA restriction endonuclease","volume":"324","author":"Zaug","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.jvs.2007.02.031_bib27","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1126\/science.2237444","article-title":"Regulation of gene expression with double-stranded phosphothioate oligonucleotides","volume":"250","author":"Bielinska","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.jvs.2007.02.031_bib28","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/35888","article-title":"Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans","author":"Fire","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.jvs.2007.02.031_bib29","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1073\/pnas.96.11.6411","article-title":"Pressure-mediated oligonucleotide transfection of rat and human cardiovascular tissues","volume":"96","author":"Mann","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2007.02.031_bib30","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1073\/pnas.91.2.664","article-title":"Tat-mediated delivery of heterologous proteins into cells","volume":"91","author":"Fawell","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2007.02.031_bib31","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1126\/science.285.5433.1569","article-title":"In vivo protein transduction: delivery of a biologically active protein into the mouse","volume":"285","author":"Schwarze","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jvs.2007.02.031_bib32","doi-asserted-by":"crossref","first-page":"10444","DOI":"10.1016\/S0021-9258(17)34080-2","article-title":"The third helix of the Antennapedia homeodomain translocates through biological membranes","volume":"269","author":"Derossi","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jvs.2007.02.031_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/nbt0598-440","article-title":"Intercellular delivery of functional p53 by the herpesvirus protein VP22","volume":"16","author":"Phelan","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jvs.2007.02.031_bib34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0165-6147(00)01447-4","article-title":"Cell-penetrating peptides","volume":"21","author":"Lindgren","year":"2000","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jvs.2007.02.031_bib35","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1073\/pnas.92.13.5855","article-title":"A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo","volume":"92","author":"Morishita","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jvs.2007.02.031_bib36","first-page":"242","article-title":"Vein graft gene therapy using E2F decoy oligonucleotides: target gene inhibition in human veins and long term resistance o atherosclerosis in rabbits","volume":"48","author":"Mann","year":"1997","journal-title":"Surg Forum"},{"key":"10.1016\/j.jvs.2007.02.031_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mtc.2001.111204","article-title":"Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy","volume":"121","author":"Ehsan","year":"2001","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib38","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0140-6736(99)09405-2","article-title":"Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-centre, randomised, controlled trial","volume":"354","author":"Mann","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jvs.2007.02.031_bib39","series-title":"PREVENT II: results of E2F decoy treatment of coronary vein bypass grafts","author":"Grube","year":"2001"},{"key":"10.1016\/j.jvs.2007.02.031_bib40","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jvs.2005.12.058","article-title":"Results of PREVENT III: a multicenter, randomized trial of edifoligide for the prevention of vein graft failure in lower extremity bypass surgery","volume":"43","author":"Conte","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/153857440503900102","article-title":"Design and rationale of the PREVENT III clinical trial: edifoligide for the prevention of infrainguinal vein graft failure","volume":"39","author":"Conte","year":"2005","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib42","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1001\/jama.294.19.2446","article-title":"Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial","volume":"294","author":"Alexander","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jvs.2007.02.031_bib43","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/01.ATV.0000116865.98067.31","article-title":"Graft-extrinsic cells predominate in vein graft arterialization","volume":"24","author":"Zhang","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jvs.2007.02.031_bib44","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.jvs.2006.06.005","article-title":"Early biomechanical changes in lower extremity vein grafts--distinct temporal phases of remodeling and wall stiffness","volume":"44","author":"Owens","year":"2006","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jvs.2006.08.048","article-title":"Elevated C-reactive protein levels are associated with postoperative events in patients undergoing lower extremity vein bypass surgery","volume":"45","author":"Owens","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.jvs.2007.02.031_bib46","first-page":"172","article-title":"Molecular biology and gene therapy in vascular disease","volume":"Vol 1","author":"Pierre-Paul","year":"2005"}],"container-title":["Journal of Vascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521407003175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0741521407003175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T15:22:25Z","timestamp":1628954545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0741521407003175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0741521407003175"],"URL":"https:\/\/doi.org\/10.1016\/j.jvs.2007.02.031","relation":{},"ISSN":["0741-5214"],"issn-type":[{"value":"0741-5214","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}